Cargando…
Follow up after sample size re-estimation in a breast cancer randomized trial for disease-free survival
BACKGROUND: While the clinical trials and statistical methodology literature on sample size re-estimation (SSRE) is robust, evaluation of SSRE procedures following the completion of a clinical trial has been sparsely reported. In blinded sample size re-estimation, only nuisance parameters are re-est...
Autores principales: | Hade, Erinn M., Young, Gregory S., Love, Richard R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708130/ https://www.ncbi.nlm.nih.gov/pubmed/31443726 http://dx.doi.org/10.1186/s13063-019-3632-9 |
Ejemplares similares
-
Follow up after sample size re-estimation in a breast cancer trial for time to recurrence
por: Hade, Erinn, et al.
Publicado: (2013) -
Interim sample size re-estimation in the IIVOP trial
por: Dawson, Sarah, et al.
Publicado: (2015) -
Randomized pilot trial for the efficacy of the MMF07 foot massager and heat therapy for restless legs syndrome
por: Park, Ariane, et al.
Publicado: (2020) -
Blinded sample size re-estimation in a comparative diagnostic accuracy study
por: Stark, Maria, et al.
Publicado: (2022) -
Application of sample size re-estimation in clinical trials: A systematic review
por: Mano, Hirotaka, et al.
Publicado: (2023)